Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/10/2026 ,inter alia, to consider and approve 1. To consider and approve the proposal for raising funds, in one or more tranches by way of issue of Equity Shares and/or Convertible Securities, including Convertible Warrants, for cash or on consideration other than cash, including by way of share swap, through preferential allotment, private ....

HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 Date: BSE Limited 29 September,2026 Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001 Dear Sir / MaSduamb:, Intimation of Board meeting to be held on Saturday, 3rd October, 2026. Ref: Scrip Code: 524590 | Symbol: HEMORGANIC | ISIN: INE422G01015 Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday, 3 October, 2026, at the Registered office of the Company to discuss and consider, inter-alia, the following matter s- 1. To consider and approve the proposal for raising funds, in one or more tranches by way of issue of Equity Shares and/or Convertible Securities, including Convertible Warrants, for cash or on sideration other than cash, including by way of share swap, through preferential allotment, private placement, qualified institutions placement (“QIP”), rights issue, further public issue or any other permissible mode or combination thereof subject to such statutory /regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and ancillary actions for such fund raising. 2. Any other agenda matter to be discussed with the permission of Chairman of the Board Meeting. Further, in terms of the Company’s “Code of Conduct to Regulate, Monitor and Report Trading by “Designated Persons” and their immediate relatives read with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed with effect from 29 September, 2026 till 48 hours after the declaration of financial Result for the Quarter and half year ended September, 2026. Kindly take the same on your record and oblige us. TFohra,n Hkienmg oY oOur ganic Limited Ayush Dharmendrabhai Jasani Chairman & Additional Director DIN: 09842741